This trial will use multiomics technology to probe the mechanisms by which prebiotics ... Dexcom 6 or 7, Medtronic continuous glucose monitoring system or Freestyle Libre (intermittent scanning ...

Abbott announced results from its REFLECT real-world studies that show the use of FreeStyle Libre continuous glucose monitoring (CGM) technology is associated with a significant reduction in the risk ...

(RTTNews) - Abbott Laboratories (ABT) Thursday announced positive data from REFLECT studies of its FreeStyle Libre continuous glucose monitoring (CGM) technology. The REFLECT studies, funded by ...

Abbott Laboratories (ABT)’s Libre Linked to Fewer Heart Hospitalizations in Diabetes For the first time, the data demonstrate that CGM technology can reduce the severity of cardiovascular issues ...

Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) technology use is linked to a significant decrease in hospitalisation risk for ...

Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its FreeStyle Libre® continuous glucose monitoring (CGM) system is linked to ...

The use of CGM technology like Libre is now associated not only with better diabetes management but also with potentially lower healthcare costs due to fewer hospital admissions related to heart ...

Abbott (NYSE: ABT), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $223.67 billion, has released findings from its REFLECT studies indicating that ...

May 15, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from its REFLECT real-world studies that show the use of FreeStyle Libre® continuous glucose monitoring (CGM) technology ...

Share on Pinterest Getty Images/Dragoljub Bankovic The FreeStyle Libre is a continuous glucose monitoring (CGM) system that doesn’t require a blood sample from a finger stick. It’s ...